CA2408319A1 - Traitement de cellules hematopoietiques base sur des antagonistes du cxcr4 - Google Patents

Traitement de cellules hematopoietiques base sur des antagonistes du cxcr4 Download PDF

Info

Publication number
CA2408319A1
CA2408319A1 CA002408319A CA2408319A CA2408319A1 CA 2408319 A1 CA2408319 A1 CA 2408319A1 CA 002408319 A CA002408319 A CA 002408319A CA 2408319 A CA2408319 A CA 2408319A CA 2408319 A1 CA2408319 A1 CA 2408319A1
Authority
CA
Canada
Prior art keywords
lkwiqeylekaln
gggg
cells
cxcr4 antagonist
sdf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002408319A
Other languages
English (en)
Inventor
Ahmed Merzouk
Lakhdar Arab
Geeta Saxena
Connie J. Eaves
Johanne Cashman
Ian Clark-Lewis
Hassan Salari
Christopher R. Tudan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Chemokine Therapeutics Corp USA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002305787A external-priority patent/CA2305787A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002408319A priority Critical patent/CA2408319A1/fr
Priority claimed from PCT/CA2001/000659 external-priority patent/WO2001085196A2/fr
Publication of CA2408319A1 publication Critical patent/CA2408319A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des antagonistes du CXCR4 qui peuvent être utilisés pour traiter des cellules hématopoiétiques, telles que des cellules souches ou progénitrices, afin de promouvoir la vitesse de multiplication, d'auto-renouvellement, de prolifération ou d'expansion cellulaire. Les antagonistes du CXCR4 peuvent être utilisés de manière thérapeutique pour stimuler la multiplication/l'auto-renouvellement de cellules souches/progénitrices hématopoiétiques.
CA002408319A 2000-05-09 2001-05-09 Traitement de cellules hematopoietiques base sur des antagonistes du cxcr4 Abandoned CA2408319A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002408319A CA2408319A1 (fr) 2000-05-09 2001-05-09 Traitement de cellules hematopoietiques base sur des antagonistes du cxcr4

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CA2,305,787 2000-05-09
CA002305787A CA2305787A1 (fr) 2000-05-09 2000-05-09 Traitement antagoniste cxcr4 de cellules hematopoietiques
US20546700P 2000-05-19 2000-05-19
US60/205,467 2000-05-19
CA002408319A CA2408319A1 (fr) 2000-05-09 2001-05-09 Traitement de cellules hematopoietiques base sur des antagonistes du cxcr4
PCT/CA2001/000659 WO2001085196A2 (fr) 2000-05-09 2001-05-09 Traitement de cellules hématopoiétiques basé sur des antagonistes du cxcr4

Publications (1)

Publication Number Publication Date
CA2408319A1 true CA2408319A1 (fr) 2001-11-15

Family

ID=27171229

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002408319A Abandoned CA2408319A1 (fr) 2000-05-09 2001-05-09 Traitement de cellules hematopoietiques base sur des antagonistes du cxcr4

Country Status (1)

Country Link
CA (1) CA2408319A1 (fr)

Similar Documents

Publication Publication Date Title
EP1286684B1 (fr) Utilisation d'antagonistes du cxcr4 pour traiter les maladies autoimmunes et le cancer
US7435718B2 (en) CXCR4 antagonist treatment of hematopoietic cells
AU2001258110A1 (en) Cxcr4 antagonist treatment of hematopoietic cells
EP1061944B1 (fr) Antagonistes therapeutiques du recepteur de chemokine
AU2001252081B2 (en) Cxcr4 agonist treatment of hematopoietic cells
US7354899B2 (en) Methods of treating autoimmune diseases comprising administering CXCR4 antagonists
US7378098B2 (en) CXC chemokine receptor 4 agonist peptides
AU2001252081A1 (en) CXCR4 Agonist Treatment of Hematopoietic Cells
WO2000009152A1 (fr) Antagonistes therapeutiques du recepteur de la chimiokine
KR100222274B1 (ko) 결합되지 않은 mpl 수용체를 사용하여 혈소판 생산을 자극하기 위한 조성물 및 방법
AU2005201244B2 (en) CXCR4 agonist treatment of hematopoietic cells
CA2408319A1 (fr) Traitement de cellules hematopoietiques base sur des antagonistes du cxcr4
CA2405907A1 (fr) Traitement de cellules hematopoietiques utilisant des agonistes de cxcr4
CA2305036A1 (fr) Traitement de cellules hematopoietiques a l'aide d'agonistes du cxcr4
CA2322764A1 (fr) Antagonistes therapeutiques du recepteur de chemokine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140509